Skip to main content

Periodontitis

Periodontitis is a group of diseases that have in common the destruction of the tooth support system. They manifest with a oss of attack and bone, formation of pockets and recession of the gingiva.
They are always preceded by gingivitis and, therefore, if the latter is prevented, it is possible to prevent the far more serious periodontitis.
The characteristic sign of periodontitis is the formation of the periodontal pocket associated with dental mobility.

World data

Severe periodontal disease is widespread, with a global prevalence of about 19% in people aged greater than 15 years, representing more than 1 billion cases worldwide 1.

1 Global oral health status report: towards universal health coverage for oral health by 2030.
World health Organization Nov 2022
Non-surgical therapy is considered the gold standard for the initial treatment of inflammatory periodontal disease.

The therapeutic approach

The use of minimally-invasive techniques in restorative dentistry is now recognized as of increasing importance, and is often in the better interests of patients.

In the light of the latest scientific evidence he Italian Society of Periodontology and Implantology (SIdP) with the aim of guiding the dentist, has drawn up guidelines in the treatment of periodontitis in its various stages of disease, in four main steps.

Step by step instructions for perio treatments

First step

Remove plaque and tartar on the supragingival sites and fensure that the patient is present at the controls with little or no plaque on the teeth.

Second step

Subgingival instrumentation with curettes and ultrasound.
Wait from 8 to 12 weeks: the goal is to obtain maximum 4 mm deep gum pockets and no bleeding.
If this goal is not achieved, the next step is taken.

Third step

Repeat the non-surgical instrumentation or evaluate the use of additional non-surgical therapies, (local antibiotics and probiotics). For serious defects surgery is necessary or the closure of the pocket and the return to a state of health of the tissues.

Fourth step

Maintenance of the control of gingival inflammation, thanks to supportive periodontal therapy.

Non-surgical therapy is considered the gold standard for the initial treatment of inflammatory periodontal disease. Ubigel Inperio®, used for initial antinfective and periodontal support therapy creates a protective layer on the surface of the treatment area; also restores the physiological levels of the membrane of the oral mucosa and promotes tissue regeneration by virtue of he spermidin contained in it.

Frequently Asked Questions

Do you have a question? We have an answer.

WHAT IS UBIGEL AND WHY CHOOSE IT?
  • What is Ubigel Inperio®?

    Ubigel Inperio® is an innovative medical device designed to support the non-surgical treatment of periodontal pockets, helping to improve clinical outcomes in a simple and effective way.

  • Why choose Ubigel Inperio®?

    Because it brings together protection, healing support and stability in a single solution—optimising treatment efficiency while enhancing both clinician workflow and patient experience.

  • How does it work?

    Once combined, the two gels form a stable protective barrier that adapts closely to the periodontal pocket, shielding it and supporting the body’s natural healing process.

CLINICAL BENEFITS
WHEN SHOULD IT BE USED
  • What are the indications?
    Is suitable for:
    • Gingivitis and periodontitis
    • Periodontal pockets, particularly in early stages
    • Supporting sensitive areas following a hygiene appointment
  • Can it be used with implants?

    Yes, it is also suitable for peri-implant sites, particularly in early-stage conditions.

EASE OF USE AND INTEGRATION
TECHNOLOGY AND COMPOSITION
  • What makes Ubigel Inperio® different?
    Its advanced formulation combines:
    • Hyaluronic acid for hydration and patient comfort
    • Spermidine to support cellular function
    • A polymer structure that forms a stable protective barrier
  • What is spermidine?

    Spermidine is a naturally occurring compound that supports cellular health and promotes tissue renewal.

PRODUCT PERFORMANCE
PATIENT EXPERIENCE
HANDLING AND SAFETY
PRACTICAL INFORMATION
AVAILABILITY AND SUPPORT
Logo Certificazione ISO
UBIGEL Imperio® is a CE-marked medical device in accordance with Council Directive 93/42/EEC

© Pierrel 2021, All rights reserved
Share Capital approved, subscribed and paid € 10.033.464,93 P.IVA 04920860964 – R.E.A. n. CE-227340
©Ubigel Imperio. All rights reserved.
Powered by IKIworks.